Exicom Tele-Systems Extends Timeline for Utilization of Unutilized IPO Proceeds to September 2026
Exicom Tele-Systems Limited has extended the timeline for utilizing ₹8.83 crores of unutilized IPO proceeds for R&D activities up to September 30, 2026, following Board approval on March 26, 2026. Out of ₹400 crores originally proposed, ₹381.34 crores had been utilized by December 31, 2025, with additional ₹9.18 crores used in Q4 FY 2025-26. The extension is due to delays in research and product development activities caused by dependencies on external collaborations and EV product rollout timelines. The company maintains compliance with regulatory requirements and has clarified that there is no change in the objects of the issue.

*this image is generated using AI for illustrative purposes only.
Exicom Tele-Systems Limited has announced an extension of the timeline for utilizing a portion of its unutilized IPO proceeds, with the Board of Directors approving the extension through a circular resolution passed on March 26, 2026. The company has extended the utilization timeline for Research & Development funds up to September 30, 2026.
IPO Proceeds Utilization Status
The company had originally proposed to utilize ₹400 crores from the IPO proceeds towards specified objects as disclosed in the Offer Documents. The current utilization status shows significant progress in fund deployment across various activities.
| Parameter | Amount (₹ crores) |
|---|---|
| Total IPO Proceeds Proposed | 400.00 |
| Utilized as of December 31, 2025 | 381.34 |
| Additional Utilization in Q4 FY 2025-26 | 9.18 |
| Remaining Unutilized for R&D | 8.83 |
| Offer-related Expenses Pending | 0.64 |
Extension Details and Timeline
The Board has specifically approved the extension for ₹8.83 crores that remains unutilized towards Research & Development activities. This amount will now have an extended timeline for utilization up to September 30, 2026. The company has clarified that an amount of approximately ₹0.64 crores pertaining to offer-related expenses is proposed to be fully utilized on or before March 31, 2026, towards general corporate purposes, and no extension of timeline is being sought for this portion.
Reasons for Extension
The extension in timeline for R&D utilization is primarily attributed to delays in research and product development activities. These delays have arisen due to dependencies on external collaborations and EV product rollout timelines. The company emphasized that there is no change in the objects of the issue as stated in the Offer Documents, and the present approval pertains solely to the extension of timeline for deployment of the remaining R&D funds.
Compliance and Fund Management
Exicom Tele-Systems has maintained the unutilized IPO proceeds in compliance with applicable provisions of the Companies Act, 2013 and the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018. The funds are currently invested in permitted interest-bearing instruments pending their utilization. The disclosure has been made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, ensuring transparency with stakeholders regarding the fund utilization timeline adjustments.
Historical Stock Returns for Exicom Tele-Systems
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.92% | -9.25% | -12.52% | -44.38% | -46.28% | -61.56% |
What specific EV products is Exicom developing through its R&D investments, and how might delays impact its competitive position in the electric vehicle charging infrastructure market?
Which external collaborations are causing the R&D timeline delays, and could these partnerships potentially be restructured or replaced to accelerate product development?
How might the extended R&D timeline affect Exicom's revenue projections and market share growth in the rapidly evolving EV charging sector?


































